蛋白质合成研究综述：2024

全球商业氨基酸市场规模预计将从 2024 年的 318 亿美元增长到 2029 年的 428 亿美元，预测期内的复合年增长率为 6.1%。

全球重组蛋白市场规模预计将从 2024 年的 1,418 亿美元成长到 2029 年的 2,036 亿美元，预测期内的复合年增长率为 7.5%。

全球聚乙二醇化蛋白质市场规模预计将从 2023 年的 102 亿美元成长到 2028 年的 159 亿美元，预测期间的复合年增长率为 9.4%。

蛋白质合成对于所有生物体都至关重要，它使细胞能够产生生存和功能所需的蛋白质。这是在细胞内建构蛋白质的基本生物过程，对每个细胞功能都至关重要。蛋白质合成的主要成分是去氧核糖核酸（DNA）、核糖核酸（RNA）、核醣体和胺基酸。

由于慢性病的增加，对蛋白质疗法的需求不断增加，这是推动该市场发展的主要因素。无细胞系统的进步以及表现载体的改进提高了效率和生产力，也推动了蛋白质合成市场的发展。新兴市场转向无细胞系统、高通量技术以及个人化医疗的转变也是蛋白质合成市场成长的主要因素。高昂的生产成本和复杂的技术正在影响市场的成长。

本研究评论包括 BCC Research 于 2024 年发布的有关商业氨基酸、重组蛋白、寡核苷酸、肽化蛋白和肽合成的报告的亮点和摘录，并包括每个市场的全面概述、市场影响因素和市场机会的分析、法律制度、新兴技术和技术发展、市场规模趋势和预测，以及各个细分市场和地区的详细分析。

目录

第 1 章 简介

第 2 章 商业氨基酸（BIO007N）

• 市场展望
• 研究范围
• 市场摘要
• 市场概况
• 商业利益
• 化学结构
• 市场动态
• 市场驱动因素
• 市场限制
• 市场挑战
• 市场机会
• 法律规范
• 全球法规结构
• 各类应用的监理要求
• 品管和製造标准
• 新兴技术和发展
• 代谢工程与合成生物学
• 高通量筛检与发酵优化
• 常规流动生物催化剂
• 先进的层析法技术
• 羟基氨基酸
• 绿色化学与永续生产
• 主要市场趋势
• 商业胺基酸：世界市场
• 商业胺基酸市场（按产品类型）
• 甲硫胺酸
• 离胺酸
• 苏胺酸
• 色氨酸
• 苯丙胺酸
• 麸胺酸
• 半胱胺酸
• 天门冬胺酸
• 甘胺酸
• 丙胺酸
• 精胺酸
• 脯胺酸
• 亮氨酸
• 巴林
• 酪胺酸
• 其他的
• 商业胺基酸市场（按应用）
• 动物饲料
• 食品调味料
• 特殊用途
• 商业胺基酸市场（按地区）
• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 世界其他地区
• 商业胺基酸的永续性：ESG 视角
• ESG：简介
• 商业胺基酸市场的永续性
• 了解 ESG资料

3. 全球重组蛋白市场 (BIO254A)

• 市场展望
• 研究范围
• 市场摘要
• 市场概况
• 表达宿主系统类型
• 重组蛋白的作用机制
• 重组蛋白生产的一般步骤
• 重组蛋白市场动态
• 驱动程式
• 限制因素
• 机会
• 重组蛋白的新技术与发展
• 蛋白质工程进展
• CRISPR基因组编辑
• 无细胞蛋白质合成
• 全球重组蛋白市场（依产品类型）
• 荷尔蒙
• 细胞激素
• 酵素
• 抗体
• 抗原
• 其他的
• 全球重组蛋白市场（按宿主细胞类型）
• 细菌宿主细胞
• 酵母菌和真菌细胞
• 哺乳动物细胞
• 昆虫细胞
• 其他的
• 全球重组蛋白市场（按应用）
• 治疗和疫苗
• 生物医学研究
• 诊断
• 全球重组蛋白市场（按地区）
• 北美洲
• 欧洲
• 亚太地区
• 其他地区
• 重组蛋白市场的永续性
• 了解 ESG资料
• ESG绩效分析
• 结论

4. 寡核苷酸：世界市场（BIO220B）

• 市场展望
• 研究范围
• 市场分析
• 市场概况
• 寡核苷酸合成的历史
• 寡核苷酸类型
• 寡核苷酸合成的替代形式
• 合成寡核苷酸的多种功能
• 寡聚治疗药物的监管途径
• 动物模型和研究
• 监理机构的作用
• 市场动态
• 市场驱动因素
• 市场限制
• 市场机会
• 各领域新应用
• 寡核苷酸的新技术和发展
• DNA合成器
• 新兴技术
• 全球寡核苷酸合成市场（按产品类型）
• 寡核苷酸药物
• 设备和试剂
• 合成寡核苷酸
• 服务
• 全球寡核苷酸合成市场（按应用）
• 研究
• 诊断和治疗
• 全球寡核苷酸合成市场（按地区）
• 北美洲
• 欧洲
• 亚太地区
• 其他地区
• 寡核苷酸市场的 ESG 趋势
• ESG：简介
• 评估寡核苷酸製造流程的永续性
• 市场中的 ESG 表现
• 结论

5. 聚乙二醇化蛋白质市场 (BIO253A)

• 市场展望
• 研究范围
• 市场摘要
• 市场概况
• 蛋白质聚乙二醇化的优势
• 聚乙二醇化疗法的局限性
• 聚乙二醇化蛋白质的市场动态
• 市场驱动因素
• 市场限制
• 市场机会
• 新兴技术和发展
• 非共用乙二醇化
• 奈米粒子的聚乙二醇化
• 抗体药物复合体(ADC)
• 全球聚乙二醇化蛋白质市场（按蛋白质类型）
• 颗粒细胞增生因子（G-CSF）
• 聚乙二醇化单株抗体
• 聚乙二醇干扰素
• 聚乙二醇化重组因子
• 其他的
• 全球聚乙二醇化蛋白质市场（依聚乙二醇化类型）
• 线性聚乙二醇化蛋白质
• 分支聚乙二醇化蛋白质
• 全球聚乙二醇化蛋白质市场（依聚乙二醇化应用）
• 自体免疫疾病
• 血液系统疾病
• 癌症
• 其他的
• 全球聚乙二醇化蛋白质市场（按区域）
• 北美洲
• 欧洲
• 亚太地区
• 其他地区
• 聚乙二醇化蛋白质市场的永续性：ESG 视角
• ESG：简介
• 聚乙二醇化蛋白质产业的永续性
• 了解 ESG资料
• ESG绩效分析
• 结论

6. 胜肽合成：世界市场（BIO252A）

• 市场展望
• 研究范围
• 市场摘要
• 胜肽疗法：市场概览
• 胜肽的重要性
• 胜肽合成
• 肽疗法的趋势
• 市场动态
• 市场驱动因素
• 市场限制
• 市场机会
• 胜肽合成和治疗剂製造的新技术
• 水介质中 SPPS 的研究进展
• 化学合成
• 胜肽药物输送
• 新开发案例：按公司
• 细分市场分析
• 全球肽合成市场（按肽类型划分）
• 合成胜肽
• 抗菌胜肽
• 荷尔蒙胜肽
• 活性胜肽
• 胶原蛋白肽
• 其他的
• 全球胜肽合成市场（按应用）
• 胜肽疗法
• 化妆品
• 营养补充品
• 其他的
• 全球胜肽合成市场（按合成类型）
• 固相
• 液相
• 杂交种
• 全球胜肽合成市场（按地区）
• 北美洲
• 欧洲
• 亚太地区
• 其他地区
• 胜肽合成产业的永续性：ESG 视角
• ESG 对于胜肽治疗药物製造商的重要性
• 胜肽治疗药物製造商的 ESG 实践
• BCC的观点

第七章 附录

The global market for commercial amino acids is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.

The global market for recombinant proteins is expected to grow from $141.8 billion in 2024 to $203.6 billion by 2029, at a CAGR of 7.5% from 2024 through 2029.

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 to $15.9 billion by 2028, at a CAGR of 9.4% from 2023 through 2028.

Research Review Scope

Protein synthesis is vital for all living organisms, enabling cells to produce the proteins they need to survive and function. It is a basic biological process that builds proteins in cells, which is essential for every cellular function. The key components of protein synthesis are Deoxyribonucleic acid (DNA), Ribonucleic acid (RNA), ribosomes, and amino acids.

The growing demand for protein therapeutics due to the increase in the prevalence of chronic diseases is a major factor driving this market. Advances in cell-free systems and improved expression vectors, which enhance efficiency and productivity, also help to boost the protein synthesis market. The developments towards cell-free systems, high-throughput technologies, and a focus on personalized medicine also act as key factors for the growth of the protein synthesis market. The high production costs and complex techniques affect the growth of the market.

The market includes major players such as Amgen Inc., Pfizer Inc., Genentech, USA Inc., and Eli Lilly, which mainly focus on protein therapeutics. The companies focusing on protein synthesis research and development include GenScript ProBio, Aldevron, Creative Biogene, and Tierra Biosciences Inc.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of protein-synthesis provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO007N Commercial Amino Acids.
• BIO254A Global Recombinant Proteins Market.
• BIO220B Oligonucleotides: Global Markets.
• BIO253A PEGylated Proteins Market.
• BIO252A Peptide Synthesis: Global Markets.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Commercial Amino Acids (BIO007N)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Commercial Interests
• Chemical Structure
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Challenges
• Market Opportunity
• Regulatory Structure
• Global Regulatory Framework
• Regulatory Requirements for Different Applications
• Quality Control and Manufacturing Standards
• Emerging Technologies and Developments
• Metabolic Engineering and Synthetic Biology
• High-throughput Screening and Fermentation Optimization
• Continuous-Flow Biocatalysis
• Advanced Chromatography Techniques
• Hydroxy Amino Acids
• Green Chemistry and Sustainable Production
• Key Market Trends
• Commercial Amino Acids: Global Markets
• Commercial Amino Acids Market, by Product Type
• Methionine
• Lysine
• Threonine
• Tryptophan
• Phenylalanine
• Glutamic Acid
• Cysteine
• Aspartic Acid
• Glycine
• Alanine
• Arginine
• Proline
• Leucine
• Valine
• Tyrosine
• Other Amino Acids
• Commercial Amino Acids Market, by Application
• Animal Feed Applications
• Food Flavoring Applications
• Specialty Uses Applications
• Commercial Amino Acids Market, by Region
• North America
• Europe
• Asia-Pacific
• LATAM
• Rest of the World
• Sustainability in Commercial Amino Acids: An ESG Perspective
• Introduction to ESG
• Sustainability in the Commercial Amino Acids Market
• Understanding the ESG Data

Chapter 3 Global Recombinant Proteins Market (BIO254A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Types of Expression Host Systems
• Mechanism of Action of Recombinant Proteins
• Common Steps Involved in Recombinant Protein Production
• Market Dynamics of Recombinant Proteins
• Drivers
• Restraints
• Opportunities
• Emerging Technologies and Developments in Recombinant Proteins
• Protein-Engineering Advances
• CRISPR Genome Editing
• Cell-Free Protein Synthesis
• Global Market for Recombinant Proteins, by Product Type
• Hormones
• Cytokines
• Enzymes
• Antibodies
• Antigens
• Others
• Global Market for Recombinant Proteins, by Host Cell Type
• Bacterial Host Cells
• Yeast and Fungi Cells
• Mammalian Cells
• Insect Cells
• Other Cells
• Global Market for Recombinant Proteins, by Application
• Therapeutics and Vaccines
• Biomedical Research
• Diagnostics
• Global Market for Recombinant Proteins, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Recombinant Proteins Market
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 4 Oligonucleotides: Global Markets (BIO220B)

• Market Outlook
• Scope of Report
• Market Insights
• Market Overview
• History of Oligonucleotide Synthesis
• Types of Oligonucleotides
• Alternative Forms of Oligonucleotide Synthesis
• Versatile Functions of Synthetic Oligonucleotides
• Regulatory Paths for Oligotherapeutics
• Animal Models and Studies
• Role of Regulatory Authorities
• Global Market Dynamics for Oligonucleotides
• Market Drivers
• Market Restraints
• Opportunities in the Market
• Emerging Applications in Various Fields
• Emerging Technologies and Developments in Oligonucleotides
• DNA Synthesizers
• Emerging Technologies
• Global Market for Oligonucleotide Synthesis, by Product Type
• Oligonucleotide Drugs
• Equipment and Reagents
• Synthesized Oligos
• Services
• Global Market for Oligonucleotide Synthesis, by Application
• Research
• Diagnostics and Therapeutics
• Global Market for Oligonucleotide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Developments in the Oligonucleotide Market
• Introduction to ESG
• Assessing the Sustainability of the Oligonucleotide Manufacturing Process
• ESG Performance in Market
• Concluding Remarks

Chapter 5 PEGylated Proteins Market (BIO253A)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Advantages of Protein PEGylation
• Limitations of PEGylated Therapeutics
• Market Dynamics for the PEGylated Proteins
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Non-Covalent PEGylation
• PEGylation of Nanoparticles
• Antibody-Drug Conjugates (ADCs)
• Global PEGylated Proteins Market, by Protein Type
• Granulocyte-Colony Stimulating Factors (G-CSF)
• PEGylated Monoclonal Antibodies
• PEGylated Interferons
• PEGylated Recombinant Factors
• Other Protein Types
• Global PEGylated Proteins Market, by PEGylation Type
• Linear PEGylated Proteins
• Branched PEGylated Proteins
• Global PEGylated Proteins Market, by PEGylation Application
• Autoimmune Diseases
• Hematology
• Cancer
• Other Applications
• Global PEGylated Proteins Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in PEGylated Proteins Market: ESG Perspective
• Introduction to ESG
• Sustainability in the PEGylated Proteins Industry
• Understanding the ESG Data
• ESG Performance Analysis
• Concluding Remarks

Chapter 6 Peptide Synthesis: Global Markets (BIO252A)

• Market Outlook
• Scope of Report
• Market Summary
• Peptide Therapeutics Market Overview
• Importance of Peptides
• Peptide Synthesis
• Trends in Peptide Therapeutics
• Market Dynamics
• Market Drivers
• Market Restraint
• Market Opportunities
• Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing
• Advances in SPPS in Aqueous Media
• Chemical Synthesis
• Peptide Drug Delivery
• Examples of New Developments, by Company
• Market Analysis, by Segment
• Global Market for Peptide Synthesis, by Peptide Type
• Synthetic Peptides
• Antimicrobial Peptides
• Hormonal Peptides
• Bioactive Peptides
• Collagen Peptides
• Other Products
• Global Market for Peptide Synthesis, by Application
• Peptide Therapeutics
• Cosmetics
• Nutraceuticals
• Other Applications
• Global Market for Peptide Synthesis, by Synthesis Type
• Solid-phase
• Solution-phase
• Hybrid-phase
• Global Market for Peptide Synthesis, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Peptide Synthesis Industry: ESG Perspective
• Importance of ESG among Peptide Therapeutics Manufacturers
• ESG Practices of Peptide Therapeutics Manufacturers
• BCC Research Viewpoint

Chapter 7 Appendix

• Research Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Commercial Amino Acids Market, by Application, Through 2029
• Table 2 : Commercial Amino Acids, by Use
• Table 3 : Protein Amino Acids
• Table 4 : Applications of Selected Amino Acids
• Table 5 : Global Commercial Amino Acids Market, Through 2029
• Table 6 : Leading Global Producers of Amino Acids, by Product Type, 2023
• Table 7 : Global Commercial Amino Acids Market, by Product Type, Through 2029
• Table 8 : Methionine Content of Selected Foods
• Table 9 : Global Commercial Amino Acids Market, by Application, Through 2029
• Table 10 : Global Commercial Amino Acids Market, by Region, Through 2029
• Table 11 : North American Commercial Amino Acids Market, by Country, Through 2029
• Table 12 : European Commercial Amino Acids Market, by Country, Through 2029
• Table 13 : Asia-Pacific Commercial Amino Acids Market, by Country, Through 2029
• Table 14 : LATAM Commercial Amino Acids Market, by Country, Through 2029
• Table 15 : RoW Commercial Amino Acids Market, by Application, Through 2029
• Table 16 : ESG Rankings for Major Commercial Amino Acids Companies, 2024*
• Table 17 : Global Market for Recombinant Proteins, by Region, Through 2029
• Table 18 : Comparison of Different Protein Expression Host Systems
• Table 19 : R&D Expenditures of Key Biopharmaceutical Companies, 2023
• Table 20 : Global Market for Recombinant Proteins, by Product Type, Through 2029
• Table 21 : Global Market for Recombinant Proteins, by Host Cell Type, Through 2029
• Table 22 : Global Market for Recombinant Proteins, by Application, Through 2029
• Table 23 : Therapeutic Applications of Recombinant Proteins, by Product Type
• Table 24 : Global Market for Recombinant Proteins, by Region, Through 2029
• Table 25 : North American Market for Recombinant Proteins, by Country, Through 2029
• Table 26 : European Market for Recombinant Proteins, by Country, Through 2029
• Table 27 : Asia-Pacific Market for Recombinant Proteins, by Country, Through 2029
• Table 28 : ESG Rankings for Major Recombinant Protein Drug Companies, 2024*
• Table 29 : ESG: Environmental Overview
• Table 30 : ESG: Social Factors Overview
• Table 31 : ESG: Governance Overview
• Table 32 : Global Market for Oligonucleotides, by Region, Through 2028
• Table 33 : Comparison of Oligonucleotide and Polynucleotide
• Table 34 : List of Approved Oligonucleotide Therapeutics, 2023
• Table 35 : Global Market for Oligonucleotide Synthesis, by Product Type, Through 2028
• Table 36 : Revenue Generated, by Few Oligonucleotide Drugs, 2022
• Table 37 : Global Market for Oligonucleotide Synthesis, by Application, Through 2028
• Table 38 : Global Market for Oligonucleotide Synthesis, by Region, Through 2028
• Table 39 : North American Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 40 : European Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 41 : Asia-Pacific Market for Oligonucleotide Synthesis, by Country, Through 2028
• Table 42 : Assessment of the Oligonucleotide Manufacturing Process Against the 12 Principles of Green Chemistry
• Table 43 : Key Focus Areas in ESG Metrics
• Table 44 : ESG Rankings for Oligonucleotide Companies, 2023*
• Table 45 : Global Market for PEGylated Proteins, by Region, Through 2028
• Table 46 : PEGylated Drugs in Clinical Trials for Cancer
• Table 47 : Discontinued PEGylated Drugs in Clinical Trials
• Table 48 : Side Effects Observed with Approved Products
• Table 49 : Global Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 50 : Marketed PEGylated G-CSF Drugs
• Table 51 : Global Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 52 : Global Market for PEGylated Proteins, by Application, Through 2028
• Table 53 : Global Market for PEGylated Proteins, by Region, Through 2028
• Table 54 : North American Market for PEGylated Proteins, by Country, Through 2028
• Table 55 : North American Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 56 : North American Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 57 : North American Market for PEGylated Proteins, by Application, Through 2028
• Table 58 : European Market for PEGylated Proteins, by Country, Through 2028
• Table 59 : European Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 60 : European Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 61 : European Market for PEGylated Proteins, by Application, Through 2028
• Table 62 : Asia-Pacific Market for PEGylated Proteins, by Country, Through 2028
• Table 63 : Asia-Pacific Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 64 : Asia-Pacific Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 65 : Asia-Pacific Market for PEGylated Proteins, by Application, Through 2028
• Table 66 : RoW Market for PEGylated Proteins, by Protein Type, Through 2028
• Table 67 : RoW Market for PEGylated Proteins, by PEGylation Type, Through 2028
• Table 68 : RoW Market for PEGylated Proteins, by Application, Through 2028
• Table 69 : ESG Risk Rankings for Major PEGylated Protein Drug Companies, 2024*
• Table 70 : ESG: Environmental Overview
• Table 71 : ESG: Social Overview
• Table 72 : ESG: Governance Overview
• Table 73 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 74 : Pros and Cons of Liquid Phase and Solid Phase Synthesis
• Table 75 : Global Cancer Incidence, 2020
• Table 76 : Emerging Trends in Peptide Synthesis Technologies
• Table 77 : Global Market for Peptide Synthesis, by Peptide Type, Through 2028
• Table 78 : Global Market for Peptide Synthesis, by Application, Through 2028
• Table 79 : Peptide-based Drugs Approved by FDA in 2021
• Table 80 : Best-Selling Peptide Therapeutics, 1982-2021
• Table 81 : Global Market for Peptide Synthesis, by Synthesis Type, Through 2028
• Table 82 : Global Market for Peptide Synthesis, by Region, Through 2028
• Table 83 : North American Market for Peptide Synthesis, by Country, Through 2028
• Table 84 : European Market for Peptide Synthesis, by Country, Through 2028
• Table 85 : Asia-Pacific Market for Peptide Synthesis, by Country, Through 2028
• Table 86 : RoW Market for Peptide Synthesis, by Country, Through 2028
• Table 87 : Role of ESG in Environmental Performance
• Table 88 : Role of ESG in Social Performance
• Table 89 : Role of ESG in Governance Performance
• Table 90 : ESG Rankings for Major Peptide Therapeutics Companies, 2023*

List of Figures

• Figure 1 : Snapshot of the Market Dynamics for Commercial Amino Acids
• Figure 2 : Global Commercial Amino Acids Market Share, by Product Type, 2023
• Figure 3 : Global Commercial Amino Acids Market Share, by Application, 2023
• Figure 4 : Global Commercial Amino Acids Market Share, by Region, 2023
• Figure 5 : North American Commercial Amino Acids Market Share, by Country, 2023
• Figure 6 : European Commercial Amino Acids Market Share, by Country, 2023
• Figure 7 : Asia-Pacific Commercial Amino Acids Market Share, by Country, 2023
• Figure 8 : LATAM Commercial Amino Acids Market Share, by Country, 2023
• Figure 9 : Global Market Shares of Recombinant Proteins, by Region, 2023
• Figure 10 : Basic Steps Involved in Recombinant Protein Production
• Figure 11 : Snapshot of the Market Dynamics of Recombinant Proteins
• Figure 12 : Global Biopharmaceutical R&D Expenditures, 2020-2026
• Figure 13 : Applications of Recombinant Antibodies
• Figure 14 : Advantages and Disadvantages of Continuous Manufacturing
• Figure 15 : Global Market Shares of Recombinant Proteins, by Product Type, 2023
• Figure 16 : Advantages of Recombinant Antibodies
• Figure 17 : Global Market Shares of Recombinant Proteins, by Host Cell Type, 2023
• Figure 18 : Global Market Shares of Recombinant Proteins, by Application, 2023
• Figure 19 : North American Market Shares of Recombinant Proteins, by Country, 2023
• Figure 20 : European Market Shares of Recombinant Proteins, by Country, 2023
• Figure 21 : Asia-Pacific Market Shares of Recombinant Proteins, by Country, 2023
• Figure 22 : Key ESG Metrics of Recombinant Protein Companies
• Figure 23 : Global Market Shares of Oligonucleotides, by Region, 2022
• Figure 24 : Classification of Synthetic Oligonucleotides
• Figure 25 : Dynamics of the Global Market for Oligonucleotides
• Figure 26 : Global Market Shares of Oligonucleotide Synthesis, by Product Type, 2022
• Figure 27 : Global Market Shares of Oligonucleotide Synthesis, by Application, 2022
• Figure 28 : North American Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 29 : European Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 30 : Asia-Pacific Market Shares of Oligonucleotide Synthesis, by Country, 2022
• Figure 31 : How a Strong ESG Proposition Benefits Businesses
• Figure 32 : ESG Adoption Level across Industries, 2021 and 2022
• Figure 33 : Advantages of Protein PEGylation
• Figure 34 : Timeline of PEGylated Protein Therapeutics
• Figure 35 : Disadvantages of PEGylated Protein Therapeutics
• Figure 36 : Market Dynamics of Global PEGylated Proteins
• Figure 37 : Emerging Technologies in the PEGylated Proteins Market
• Figure 38 : Global Market Shares of PEGylated Proteins, by Protein Type, 2022
• Figure 39 : Global Market Shares of PEGylated Proteins, by PEGylation Type, 2022
• Figure 40 : Global Market Shares of PEGylated Proteins, by Application, 2022
• Figure 41 : Global Market Shares of PEGylated Proteins, by Region, 2022
• Figure 42 : North American Market Shares of PEGylated Proteins, by Country, 2022
• Figure 43 : European Market Shares of PEGylated Proteins, by Country, 2022
• Figure 44 : Asia-Pacific Market Shares of PEGylated Proteins, by Country, 2022
• Figure 45 : Snapshot of ESG Pillars
• Figure 46 : Advantages of ESG for Companies
• Figure 47 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 48 : Trends in Peptide Therapeutics Manufacturing
• Figure 49 : Snapshot of the Market Dynamics for Peptide Synthesis
• Figure 50 : India's Biotechnology Sectoral Thrust
• Figure 51 : Global Projected Incidence of Diabetes, Patients Aged 20-79 Years, 2010 and 2030
• Figure 52 : Global Infectious Disease Outbreaks, 2020 to 2022
• Figure 53 : Global Infectious Disease Outbreak, 2022
• Figure 54 : Snapshot: Key Trends in Peptide Drugs and Therapeutics Technologies
• Figure 55 : Global Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 56 : Global Market Shares of Peptide Synthesis, by Application, 2022
• Figure 57 : Global Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 58 : Global Market Shares of Peptide Synthesis, by Region, 2022
• Figure 59 : North American Market Shares of Peptide Synthesis, by Application, 2022
• Figure 60 : North American Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 61 : North American Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 62 : North American Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 63 : North American Market Shares of Peptide Synthesis, by Country, 2022
• Figure 64 : European Market Shares of Peptide Synthesis, by Application, 2022
• Figure 65 : European Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 66 : European Market Shares of Peptide Synthesis, by Peptide Type, 2022
• Figure 67 : European Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 68 : European Market Shares of Peptide Synthesis, by Country, 2022
• Figure 69 : Asia-Pacific Market Shares of Peptide Synthesis, by Application, 2022
• Figure 70 : Asia-Pacific Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 71 : Asia-Pacific Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 72 : Asia-Pacific Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 73 : Asia-Pacific Market Shares of Peptide Synthesis, by Country, 2022
• Figure 74 : RoW Market Shares of Peptide Synthesis, by Application, 2022
• Figure 75 : RoW Market Shares of Peptide Therapeutics in Peptide Synthesis, by Application, 2022
• Figure 76 : RoW Market Shares of Peptide Synthesis, by Peptide Types, 2022
• Figure 77 : RoW Market Shares of Peptide Synthesis, by Synthesis Type, 2022
• Figure 78 : RoW Market Shares of Peptide Synthesis, by Country/Region, 2022
• Figure 79 : Snapshot: Key ESG Trends in Peptide Therapeutics Industry